A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Ibandronate Sodium, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Ibandronate Sodium impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Ibandronate Sodium-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Ibandronate Sodium Related Compounds

API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Ibandronate sodium API Standards CS-O-01646 138844-81-2 In Stock
Ibandronate Sodium Monohydrate API Standards CS-O-01683 138926-19-9 In Stock


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Methyl 3-​(Methyl(pentyl)​amino)​propanoate Impurities CS-T-94035 744266-99-7 Enquire
N-Desmethyl Ibandronate Sodium Impurities CS-T-16256 953805-81-7 In Stock
N-methyl pentanamide Impurities CS-EC-00085 6225-10-1 Enquire